THE B29 AND MB-1 POLYPEPTIDES ARE DIFFERENTIALLY EXPRESSED DURING HUMAN B-CELL DIFFERENTIATION

被引:69
作者
MASON, DY
VANNOESEL, CJM
CORDELL, JL
COMANSBITTER, WM
MICKLEM, K
TSE, AGD
VANLIER, RAW
VANDONGEN, JJM
机构
[1] UNIV HOSP ROTTERDAM,SOPHIA CHILDRENS HOSP,DEPT PAEDIAT,ROTTERDAM,NETHERLANDS
[2] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS
[3] ERASMUS UNIV,DEPT IMMUNOL,3000 DR ROTTERDAM,NETHERLANDS
[4] UNIV OXFORD SIR WILLIAM DUNN SCH PATHOL,MRC,CELLULAR IMMUNOL UNIT,OXFORD OX1 3RE,ENGLAND
关键词
D O I
10.1002/eji.1830221044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surface immunoglobulin on mouse B cells is associated with a heterodimer comprising the products of the mb-1 and B29 genes. Here we report that antibodies raised against a peptide sequence from the intracytoplasmic C terminus of the B29 murine gene product detect the 37-kDa component of the human heterodimer, indicating that this component in man is also encoded by the B29 gene. The immunocytochemical reactivity of these anti-B29 antibodies was compared with those of antibodies to the mb-1 protein. Of 25 cases of acute lymphoblastic leukaemia (ALL), 24 were positive for mb-1 whereas B29 was expressed in only 13 cases. Most of these B29-positive ALL expressed immunoglobulin mu heavy chain in their cytoplasm (pre-B ALL). In lymphoid tissue sections, anti-B29-labeled B cell follicles in a similar fashion to anti-mb-1, with the striking exception that plasma cells were unreactive for B29, but positive for mb-1. These results suggest that the synthesis of B29 begins later in precursor B cells than that of mb-1, and ceases before the terminal plasmacyte phase.
引用
收藏
页码:2753 / 2756
页数:4
相关论文
共 19 条
[11]   NORMAL PRE-B CELLS EXPRESS A RECEPTOR COMPLEX OF MU HEAVY-CHAINS AND SURROGATE LIGHT-CHAIN PROTEINS [J].
NISHIMOTO, N ;
KUBAGAWA, H ;
OHNO, T ;
GARTLAND, GL ;
STANKOVIC, AK ;
COOPER, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6284-6288
[12]   THE B-CELL ANTIGEN RECEPTOR COMPLEX [J].
RETH, M ;
HOMBACH, J ;
WIENANDS, J ;
CAMPBELL, KS ;
CHIEN, N ;
JUSTEMENT, LB ;
CAMBIER, JC .
IMMUNOLOGY TODAY, 1991, 12 (06) :196-201
[13]   LYMPHOCYTE-B LINEAGE-RESTRICTED EXPRESSION OF MB-1, A GENE WITH CD3-LIKE STRUCTURAL-PROPERTIES [J].
SAKAGUCHI, N ;
KASHIWAMURA, S ;
KIMOTO, M ;
THALMANN, P ;
MELCHERS, F .
EMBO JOURNAL, 1988, 7 (11) :3457-3464
[14]   MONOCYTOID CELLS IN REACTIVE FOLLICULAR HYPERPLASIA WITH AND WITHOUT MULTIFOCAL HISTIOCYTIC REACTIONS - AN IMMUNOHISTOCHEMICAL STUDY OF 21 CASES INCLUDING SUSPECTED CASES OF TOXOPLASMIC LYMPHADENITIS [J].
SHEIBANI, K ;
FRITZ, RM ;
WINBERG, CD ;
BURKE, JS ;
RAPPAPORT, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 81 (04) :453-458
[15]  
VANDONGEN JJM, 1988, BLOOD, V71, P603
[16]  
VANNOESEL CJM, 1991, J IMMUNOL, V146, P3881
[17]   IDENTIFICATION OF 2 DISTINCT PHOSPHOPROTEINS AS COMPONENTS OF THE HUMAN B-CELL ANTIGEN RECEPTOR COMPLEX [J].
VANNOESEL, CJM ;
BORST, J ;
DEVRIES, EFR ;
VANLIER, RAW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (12) :2789-2793
[18]   COMPARISON OF HUMAN B-CELL ANTIGEN RECEPTOR COMPLEXES - MEMBRANE-EXPRESSED FORMS OF IMMUNOGLOBULIN (IG)M, IGD, AND IGG ARE ASSOCIATED WITH STRUCTURALLY RELATED HETERODIMERS [J].
VANNOESEL, CJM ;
BROUNS, GS ;
VANSCHIJNDEL, GMW ;
BENDE, RJ ;
MASON, DY ;
BORST, J ;
VANLIER, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1511-1519
[19]   CHARACTERIZATION OF A HUMAN PLASMACYTOMA LINE [J].
WEINREICH, SS ;
VONDEMBORNE, AEGK ;
VANLIER, RAW ;
FELTKAMP, CA ;
SLATER, RM ;
WESTER, MR ;
ZEIJLEMAKER, WP .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (02) :226-234